Detailed Notes on Gestational Weight Gain and Maternal and Infant Outcomes.

Introduction
  • Significance: Both low and high gestational weight gain correlate with adverse maternal and infant outcomes. The ideal gestational weight gain is not precisely defined across different prepregnancy weight categories.
  • Aim of the Study: This research focuses on explaining how different ranges of gestational weight gain affect maternal and infant outcomes and aims to estimate optimal weight gain ranges based on prepregnancy BMI categories.
Study Design and Participants
  • Design: An individual participant-level meta-analysis was performed, incorporating data from 196,670 participants across 25 cohort studies from Europe and North America.
  • Validation Sample: Data from an additional 3,505 participants from four hospital-based cohorts was used for validation.
  • Data Collection Period: The data was amassed from 1989 until December 2015.
Key Variables
  • Main Exposure: Gestational weight gain.
  • Main Outcomes: Adverse outcomes were identified as occurrences of preeclampsia, gestational hypertension, gestational diabetes, cesarean delivery, preterm birth, and abnormal infant size for gestational age.
  • BMI Classification: Participants were categorized based on BMI:
    • Underweight (BMI < 18.5)
    • Normal weight (BMI 18.5-24.9)
    • Overweight (BMI 25-29.9)
    • Obesity grade 1 (BMI 30-34.9)
    • Obesity grade 2 (BMI 35-39.9)
    • Obesity grade 3 (BMI ≥ 40.0)
Results Overview
  • Adverse Outcomes: Overall, 37.2% of women experienced at least one adverse outcome, with rates varying significantly by BMI:
    • Underweight: 34.7%
    • Obesity grade 3: 61.1%
  • Optimal Gestational Weight Gain Ranges:
    • Underweight: 14.0 kg to <16.0 kg
    • Normal Weight: 10.0 kg to <18.0 kg
    • Overweight: 2.0 kg to <16.0 kg
    • Obesity grade 1: 2.0 kg to <6.0 kg
    • Obesity grade 2: Weight loss or gain of 0 kg to <4.0 kg
    • Obesity grade 3: Weight gain of 0 kg to <6.0 kg
  • Predictive Value: The gestational weight gain ranges showed limited predictive value for adverse outcomes (area under the receiver operating characteristic curve: 0.55-0.76).
Discussion
  • Findings Interpretation: The analysis demonstrated that both gestational weight gain and prepregnancy BMI significantly influence the risk of adverse outcomes. The optimal gestational weights identified may assist in prenatal counseling, but their predictive ability for adverse outcomes was limited.
  • Focus on Prepregnancy BMI: Results suggest a stronger correlation between prepregnancy BMI and adverse outcomes than with gestational weight gain itself.
Implications for Prenatal Counseling
  • Clinical Relevance: These findings provide a comprehensive understanding of the necessary weight gain during pregnancy across various BMI categories and highlight the importance of monitoring prepregnancy BMI more closely for better maternal-infant health outcomes.
Limitations of the Study
  • Contribution of Cohorts: Not all invited cohorts participated; thus, results can be context-specific.
  • Data Limitations: Use of self-reported data may lead to misclassification and other biases.
  • Outcome Variability: Not all adverse outcomes were accounted similarly, and some seriousness differences were unmeasured.
Conclusion
  • This meta-analysis presents evidence on how gestational weight gain relates to maternal and infant health, suggesting that optimal gestational weight gain varies by prepregnancy BMI but holds limited predictive value for adverse outcomes. Future guidance should focus more on prepregnancy weight as a critical factor for intervention.